Clinical results of the total skin electron irradiation of the mycosis fungoides in adults. Conventional fractionation and low dose schemes
- PMID: 24936327
- PMCID: PMC4054994
- DOI: 10.1016/j.rpor.2013.08.008
Clinical results of the total skin electron irradiation of the mycosis fungoides in adults. Conventional fractionation and low dose schemes
Abstract
Background: Mycosis fungoides (MF) is a rare skin condition, effectively treated by irradiation. Since 1951, different methods of total skin irradiation have been developed. Although dose-response effect has been demonstrated in many publications, controversies about low dose treatment still exist.
Aim: The analysis of results of the total skin electron irradiation (TSEI), especially low dose TSEI in comparison with standard dose treatment is the subject of this review. Also, acute and late side effects of radiotherapy in MF are discussed.
Materials and methods: Medline search and analysis of studies published between 1995 and 2012, containing key words: mycosis fungoides, standard dose TSEI, low dose TSEI, total skin electron beam therapy (TSEBT).
Results: Detailed analysis of relevant studies demonstrated that standard dose radiotherapy 30-36 Gy is the most effective treatment used in clinical practice. Objective response rate (ORR) is high, especially for less advanced stages of disease. Complete response rate (CR), although slightly lower, is still relatively high. For more advanced MF, TSEI serves as a very good method of palliative treatment and relief of symptoms, like pruritus, pain or desquamation. There is no consensus regarding low dose TSEI; the method is widely accepted as a palliative treatment or in case of reirradiation.
Conclusions: Standard dose TSEI is an effective method of MF treatment for radical and palliative treatment, producing high rate of ORR and reasonably long time to progression (TTP). Acute and late side effect of treatment are mostly mild and easy to manage. Low dose TSEI is still in the phase of clinical studies.
Keywords: Low dose TSEI; Mycosis fungoides; Standard dose TSEI; Total skin electron beam therapy (TSEBT).
References
-
- Kim Y.H., Liu L.H., Mraz-Gernhardt S. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome. Arch Dermatol. 2003;139:857–866. - PubMed
-
- Kim Y.H., Chow S., Varghese A. Clinical characteristic and long term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol. 1999;135:26–32. - PubMed
-
- Chinn D., Chow S., Kim Y. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Int J Radiat Oncol Biol Phys. 1999;43(5):951–958. - PubMed
-
- Funk A., Hensley F., Krempien R. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma. Eur J Dermatol. 2008;18(3):308–312. - PubMed
-
- Kuten A., Rosenblatt E., Dale J. Total skin electron Irradiation: efficacy in early mycosis fungoides. Leuk Lymphoma. 1992;10:281–285. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
